Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH Accelerates Software Development To Improve Collaboration With Industry

This article was originally published in The Gray Sheet

Executive Summary

FDA’s device center hopes the effort, which is intended to model a quicker-turnaround “Silicon Valley” approach to system development, will help reduce time-to-market for new devices, and simplify some post-market surveillance efforts.

Advertisement

Related Content

CDRH Entrepreneurs Take Two: Streamlining Data Collection And The Path To Reimbursement
FDA Releases Proposed Rule On UDI System, Ushering in ‘Modern Post-Market Surveillance System’
CDRH Launches ‘Innovation Pathway 2.0’ With End-Stage Renal Devices
Start-Up FDA? CDRH Seeks Entrepreneurial Spirit With New “In-Residence” Program

Topics

Advertisement
UsernamePublicRestriction

Register

MT031549

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel